Santarus (SNTS) Receives $20M Milestone Payment for ZEGERID U.S. FDA Approval
Tweet Send to a Friend
Santarus, Inc. (NASDAQ: SNTS) today announced that it has received the $20 million milestone payment previously announced on December 1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
